RE:Just did some homework on LEAF...richc3 wrote: Started a position in LEAF earlier in the day -- anyone else? While researching also came across this interesting tidbit...
> LEAF is one of the industry leaders in Canada. For the quarter ended December 2016, reported sales were C$10.4 million. By comparison, generally accepted leader Canopy Growth (OTCPK:TWMJF) reported sales of C$9.0 million for the same quarter. But WEED's acquisition of Mettrum Health closed in January 2017 so they probably retain the title of 'king of the hill'. But LEAF is a leader with a reported 19% market share in August 2016 and reports a monthly market share of 15% to 20%.
Check out these numbers for December: https://i.imgur.com/tqe8IlE.png
Long SEDAR document with tons of information: https://www.sedar.com/CheckCode.do;jsessionid=0000t-rEEonb339VV14OyqTRGnT:188setvlh
lots of info.
Metrics largely better than CGC as at Dec/16.
The two I want watch before entering is: price per gram and usage per patient.
They have lots of vets that will be affected by VAC decision to reduce their reimbursement to $8.50/gram (Nov/16) and reduction to from 10/gram to 3/grams a day (May/17).
Aphria noted the first in their flat sales for last Q.
Interesting company.
GoBlue